|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 17753966.5 (espacenet) (Federated) (European Patent Register), 20170217 | | Patent/reg. no. and date | DK/EP 3416675, 20210324 | | Publication date | 20181226 | | Priority no. and date | US 201662297759 P, 20160219 | | EP pub. no. and date |
EP 3416675 20181226 | | Effective date | | | Applicant/owner | Eiger Biopharmaceuticals, Inc., 2155 Park Boulevard
Palo Alto, CA 94306, US | | Applicant ref. no. | V2105-013-DK | | Inventor | MARTINS, Eduardo Bruno, c/o Eiger Biopharmaceuticals, Inc.
2155 Park Boulevard
Palo Alto
California 94306, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 38/21 (2006.01) , A61P 1/16 (2006.01) , A61P 31/14 (2006.01) | | Title | BEHANDLING AF HEPATITIS-DELTA-VIRUSINFEKTION MED INTERFERON LAMBDA | | Int. application no. | US2017018466 | | Int. publication no. | WO2017143253 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
